期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

乳果糖治疗肝性脑病60例临床观察 被引量：3

下载PDF
导出
摘要 目的探讨乳果糖对肝性脑病(HE)的治疗作用。方法从临床选取60例HE患者,随机分为2组,每组30例。对照组给予常规治疗维生素C0.2g,potid;乳果糖组给予常规治疗乳果糖10ml,potid;观察12周,在治疗前后分别做血氨水平和NCT测定。结果治疗前2组血氨NCT比较,差异无显著性(P>0.05)。治疗后乳果糖组的血氨水平和NCT较对照组明显降低,差异有显著性(P<0.05)。2组自身治疗前后比较,两指标均存在显著性差异(P<0.001)。治疗后对照组的总有效率为56.7%,乳果糖组的总有效率为83.3%,2组比较差异有显著性(P<0.025)。结论乳果糖能有效地降低HE患者的血氨水平,改善其智力,且安全价廉。
作者 谭志纯
机构地区 湖南省益阳市第四人民医院
出处 《中国现代医药杂志》 2010年第4期88-89,共2页 Modern Medicine Journal of China
关键词 肝性脑病 乳果糖 治疗效果
分类号 R747.9 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献4

二级参考文献16

  • 1Cordoba J, Lopez-Hellin J, Planas M, et al. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. J Hepatol, 2004, 41: 38-43.
  • 2Als Nielsen B, Gluud LL, Gluud C. Non-absorbable disaccharides for hepatic encephalopathy: systemalic review of randomised trials. BMJ, 2004, 328:1046.
  • 3Bass NM. Review article: the current pharmacological therapies for hepatic encephalopathy. Aliment Pharmacol Ther, 2007, 25 (Suppl. 1): 23-31.
  • 4Mas A, Rodes J, Sunyer L, et al. Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double blind, double dummy, controlled clinical trial. J Hepatol, 2003, 38:51-58.
  • 5Leevy CB, Phillips JA. Hospitalizations during the use of Rifaximin versus lactulose for lhe Treatment of Hepatic Encephalopathy. Dig Dis Sci, 2007, 52:737-741.
  • 6Gentile S, Guarino G, Romano M, et al. A randomized controlled trial of acarbose in hepatic encephalopathy. Clin Gastroenterol Hepatol, 2005, 3:184-191.
  • 7Kircheis G, Wettstein M, Dahl S, et al. Clinical efficacy of L- ornithine-L-aspartate in the management of hepatic encephalopathy. Metab Brain Dis, 2002, 17: 453-462.
  • 8Bianchi G, Marzocchi R, Agostini F, et al. Update on branched chain amino acid supplementation in liver diseases. Curr Opin Gastroenterol, 2005, 21: 197-200.
  • 9Sehmidt LE, Tofteng F, Strauss GI, et al. Effect of treatment with the Molecular Adsorbents Recirculating System on arterial amino acid levels and cerebral amino acid metabolism in patients with hepatic encephalopathy. Stand J Gastroenterol, 2004, 39: 974-980.
  • 10Keeffe EB. Liver transplantation: current status and novel approaches to liver replacement. Gastroenterology, 2001, 120:749-762.

共引文献437

同被引文献32

  • 1高明生,李志红.MELD、MELD-Na、MELD-AS、iMELD、MESO评分体系对TIPS术后肝性脑病发生危险性预测价值的探究[J].中文科技期刊数据库（文摘版）医药卫生,2016(10):209-210. 被引量：1
  • 2邢卉春.肝性脑病诊断治疗专家共识[J].中国肝脏病杂志（电子版）,2009,1(2):46-55. 被引量：39
  • 3王良静,蔡建庭,陈涛,吕宾,姒健敏.幽门螺杆菌感染对高氨血症和肝性脑病发病的影响[J].中华内科杂志,2006,45(8):654-657. 被引量：14
  • 4张九妹,徐秀英,张月英.352例肝性脑病的诱因与预后[J].传染病信息,2007,20(4):246-247. 被引量：9
  • 5金惠铭,王建枝.病理生理学.第7 版.北京:人民卫生出版社,2010.
  • 6Romero-Gómez M,Jover M,Del Campo JA,et al.Variations in the promoter region of the glutaminase gene and the development of hepatic encephalopathy in patients with cirrhosis:a cohort study.Ann Intern Med,2010,153(5):281-288.
  • 7Guarner-Argente C,Sánchez E,Vidal S,et al.Toll-like receptor 4 D299G polymorphism and the incidence of infections in cirrhotic patients[J].Aliment Pharmacol Ther,2010,31(11):1192-1199.
  • 8Shawcross DL.Sharifi Y.Canavan JB.et al.Infection and systemic inflammation,not ammonia,are associated with Grade 3/4 hepatic encephalopathy,but not mortality in cirrhosis.J Hepatol,2011.54(4):640-9.
  • 9Albrecht J,Norenberg MD.Glutamine:a Trojanhorse in ammonia neurotoxicity.Hepatology,2006,44(4):788-794.
  • 10Gunter KK,Aschner M,Miller LM,et al.Determining the oxidation states of manganese in NT2 cells and cultured astrocytes.Neurobiol Aging,2006,27(2):1816-1826.

引证文献3

二级引证文献10

中国现代医药杂志
2010年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部